Foreign Direct Investments

Investment proposal of the project

«Production of the drugs for the treatment of endocrine diseases»

1. ProjectTitle -  “Production the drugs for the treatment of endocrine diseases”

2. General information about the project initiator: “Uzpharmsanoat” SJSC

Name and details - Tashkent city, Bodomzor yuli str., 1-a, tel. 234-06-04, fax 235-78-01.

Major type of activity – pharmaceuticals.

Major economic and financial indicators (cost and scope of products, services, export, trade and other) – scope of SJSC “Uzpharmsanoat” production for 2010 amounted to 138.4 billion sum (growth rate 156%). In this case, drug products produced in the amount of 126 billion sum (growth rate 156%). Utilization of production capacity for the current year was 70.6%, an increase of 13.9%. Working-out of production increased from 45.1 million sum to 54.8 million sum (growth rate 121.4%). The forecast 992 thousand USD, export of concern production for current year was 1 177.3 thousand USD (118.7% of the forecast) or 151.6% over the same period of last year. The drugs were shipped in the amount of 963.6 thousand USD (121.7% of the forecast) and amounted to 81.8% of total exports.

Previously completed projects, including the attraction of foreign investments and loans – of 45 investment projects to the amount of 26.5 million USD, provided in modernization program, technical and technological renewal is actually implemented 35 projects to the amount of 22.3 million USD. In 2011-2015 years provided implementation of 54 projects to the amount of 738 million USD, within the framework of industry development priorities in the Republic of Uzbekistan.

3.  Information about the Company, on the basis of which it is planned to implement the project (if available):

The project is supposed construction of a new plant. Location will be determined after technical-economical calculations.

4.     Information about project: Project is planned to organize a production the drugs for the treatment of endocrine diseases. Location will be determined after technical-economical calculations. The project is necessary to negotiate with suppliers of technological line for production the drugs for the treatment of endocrine diseases.

            Marketing:

Suggested product to production, forecasted scope of service and production.

The project is supposed of production the drugs for the treatment of endocrine diseases. Annual scope of production at full capacity will amount to 5000 conventional units.

Marketing research results with an assessment of domestic sales and export.

Project is planned the sale of finished products in the domestic market at a rate of 75% of annual capacity, 25% for export.

The main producers of similar products (competitors) in the country, in the region, the external market.

Assessment of the competitiveness of products in terms of quality and price indicators.

The project is planned the utilization of modern technological equipment, allow to produce products, which meet quality requirements. According to preliminary calculations, the price characteristics of products are not higher than similar imported.

            Manufacture:

Provision of project and other raw material resources, with an estimate of the price, quantity and quality, comparing prices of imports.

The expected response to the installation of technology and its basic parameters (performance, estimated cost, the consumption of energy and material resources, etc.).

Supposed production capacity will be 5000 conventional units.

The number of necessary staff, including engineers and workers - will be determined after the technical-economical calculations.

            Construction, reconstruction and modernization:

Direction of investments - new construction;

Requirements to ensure the production infrastructure, length, capacity / power (highway, railway line, water supply, sewerage, heating, gas, electricity, heating)

The requirements will be determined after technical-economical calculations of the project.

            Financing:

Estimated project cost, including the cost of construction or reconstruction - 12 million USD.

Approximate date of entry into maintenance of object, according to installed program of development – 2015.

The proposed scheme of financing the project by initiator.

The project is expected to attract foreign investment in the 8 million USD and borrow from commercial banks in the 6 870.00 million sum.

5. Expected results from the project implementation.

Expected annual revenue and net profit.

Expected scope of output in monetary terms at full capacity is 17 500 million sum, the net profit will then reach 2 625 million sum in a year.

Export scope.

The project is expected to export 25% of the total production, which will be in terms of money 2.55 million USD.

6.     State of development and examination of documentation on the project - will be determined after specification of the investor.

Прослушать

Налатинице

Passport

of the investment proposal “Production of the drugs for the treatment of endocrine diseases”

1.      Organization – project initiator–“Uzpharmsanoat” SJSC.

2.      Objective of the project (project brief)–Organization of production the drugs for the treatment of endocrine diseases.

3.      Direction of investments (new construction/modernization or technical re-equipment/other directions) – new construction.

4.      By the Government of Uzbekistan on the implementation of the project –Presidential Decree № PP 1442 on 15.12.2011.

5.      Availability of Government guarantee (if required) –not defined.

6.      State of development expertise pre feasibility study / feasibility study –will be determined after specification of the investor.

7.      Foreign partner and investor (including the lender, the general contractor) –worked out.

8.      Location of project (region, district, city) – not defined.

Note: 1 U.S. dollar = 1,717.5 UZS